RNA Disease Diagnostics Expands Board of Directors
April 04, 2022 11:02 ET
|
RNA Disease Diagnostics Inc.
- Lead Co-Inventor and Licensor of RNADD’s Molecular Diagnostics Platform to Help Guide its Commercialization - - Company’s President Expands Role - BALTIMORE, April 04, 2022 (GLOBE NEWSWIRE) --...
RNA Disease Diagnostics Secures Exclusive License to Ground-Breaking RNA-Based Molecular Lateral Flow Assay Technology
November 09, 2021 08:00 ET
|
RNA Disease Diagnostics Inc.
- License Enables Development of RNADD’s AntiSense Molecular Diagnostic Platform for Home-Use Infectious Disease Testing - BALTIMORE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics,...
Board-Certified Internist and Renowned Professional Sports Team Physician, Dr. Michael S. Farber, Joins RNA Disease Diagnostics’ Advisory Board
September 02, 2021 10:09 ET
|
RNA Disease Diagnostics Inc.
BALTIMORE, Sept. 02, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics, Inc. (RNADD), a company developing a best-in-class molecular diagnostics platform to democratize point-of-care and home-use...
Accomplished Healthcare Industry Veteran, Richard G. Ganz, Joins RNA Disease Diagnostics’ Board of Directors
July 08, 2021 08:30 ET
|
RNA Disease Diagnostics Inc.
BALTIMORE, July 08, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics, Inc. (RNADD), a company developing a best-in-class molecular diagnostics platform for infectious disease detection, announced...
RNA Disease Diagnostics Announces University of Maryland School of Medicine Laboratory Secures FDA Registration and Approval as Development Site for Antisense COVID-19 Test
June 03, 2021 09:00 ET
|
RNA Disease Diagnostics Inc.
BALTIMORE, June 03, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics, Inc. (RNADD), a company developing a best-in-class molecular diagnostics platform for infectious disease detection, announced...
RNA Disease Diagnostics Further Strengthens Executive Leadership with Appointment of John W. Erickson, Jr. as President
June 01, 2021 08:00 ET
|
RNA Disease Diagnostics Inc.
BALTIMORE, June 01, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics, Inc. (RNADD), a company developing a best-in-class molecular diagnostics platform for infectious disease detection, announced...
RNA Disease Diagnostics Announces Inaugural Joint Meeting of Expanded Board of Directors and Advisory Board
May 11, 2021 08:45 ET
|
RNA Disease Diagnostics Inc.
BALTIMORE, May 11, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics, Inc. (RNADD), a company developing a best-in-class molecular diagnostics platform for infectious disease detection, announced...
RNA Disease Diagnostics Announces Publication of Stepwise Protocol for Molecular Diagnosis of COVID-19 in Esteemed Journal, Nature Protocols
May 06, 2021 10:58 ET
|
RNA Disease Diagnostics Inc.
BALTIMORE, May 06, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics, Inc. (RNADD) announced today the publication of a stepwise protocol for an RNA-extraction-free nano-amplified colorimetric test...